Regenerative Engineering Society Establishes Award in Honor of MIMEDX Board Member, Dr. Cato T. LaurencinGlobeNewsWire • 08/26/22
MiMedx Group, Inc.'s (MDXG) CEO Tim Wright on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/03/22
MIMEDX to Host Second Quarter 2022 Operating and Financial Results Conference Call on August 3GlobeNewsWire • 07/20/22
MIMEDX Engages Nordic Bioscience Clinical Development A/S to Propel Registrational Trials of Placental Biologic Injectable for Knee OsteoarthritisGlobeNewsWire • 06/15/22
Prescience Point Capital Management Says MiMedx Shareholders Have Spoken: Voiced Their Desire For ChangePRNewsWire • 06/14/22
Prescience Point Capital Management Calls On MiMedx Group to Immediately Release Preliminary Voting Results of its Annual MeetingPRNewsWire • 06/07/22
MIMEDX Reminds Shareholders to Pre-Register for the Upcoming Virtual 2022 Annual Meeting of ShareholdersGlobeNewsWire • 06/03/22
MIMEDX Board Chair Dr. M. Kathleen Behrens Writes Letter to Fellow ShareholdersGlobeNewsWire • 05/31/22
Prescience Point Capital Management Releases Presentation Detailing Board And Management Failures at MiMedx GroupPRNewsWire • 05/31/22
MIMEDX Receives $4.6 Million Award from the Department of Defense to Advance the Treatment of Combat Casualty Wounds and BurnsGlobeNewsWire • 05/31/22
Leading Independent Proxy Advisory Firm ISS Recommends that MIMEDX Shareholders Vote “FOR ALL” of the Company's ProposalsGlobeNewsWire • 05/25/22
Leading Independent Proxy Advisory Firm Glass Lewis Recommends that MIMEDX Shareholders Vote “FOR ALL” of the Company's ProposalsGlobeNewsWire • 05/20/22
Prescience Point Capital Management Calls on MiMedx to Confirm the Company Has Received Letters of Serious Concern from other ShareholdersPRNewsWire • 05/18/22
Prescience Point Capital Management Issues Open Letter to Shareholders of MiMedx GroupPRNewsWire • 05/06/22
MiMedx Group, Inc. (MDXG) CEO Tim Wright on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/04/22